A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MSP / methylation-specific polymerase chain reaction

[Related PubMed/MEDLINE]
Total Number of Papers: 410
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MSP  (>> Co-occurring Abbreviation)
Long Form:   methylation-specific polymerase chain reaction
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Decreased expression of SorCS1 in colorectal cancer: An independent predictor of poor prognosis. CRC, IHC, SorCS1
2020 Epigenetic silencing of IGFBPL1 promotes esophageal cancer growth by activating PI3K-AKT signaling. ESCC, IGFBPL1, IGFBPs, IGFs
2020 Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients. PM
2020 Tissue factor pathway inhibitor 2 suppresses the growth of thyroid cancer cells through by induction of apoptosis. Lenti-TFPI-2, TFPI-2
2019 6-gene promoter methylation assay is potentially applicable for prostate cancer clinical staging based on urine collection following prostatic massage. APC2, NGM, PCa, WNT7A
2019 Alteration of oncogenic IGF-II gene methylation status associates with hepatocyte malignant transformation. HCC, IGF-II
2019 Angiotensin I-converting enzyme gene plays a crucial role in the pathology of carcinomas in colorectal cancer. CRC, qRT-PCR
2019 Correlation Between Altered DNA Methylation of Intergenic Regions of ITPR3 and Development of Delayed Cerebral Ischemia in Patients with Subarachnoid Hemorrhage. DCI, IGR, IQR, qPCR, SAH
2019 Downregulation of miR-152 contributes to DNMT1-mediated silencing of SOCS3/SHP-1 in non-Hodgkin lymphoma. NHL
10  2019 Dynamic decreased expression and hypermethylation of secreted frizzled-related protein 1 and 4 over the course of pulmonary fibrosis in mice. BLM, DNMT, SFRPs
11  2019 Evaluation of MALAT1 promoter DNA methylation patterns in early colorectal lesions and tumors. MALAT1
12  2019 Over-expression of TGF-beta1 gene in medication free Schizophrenia. ---
13  2019 p16 promoter methylation, expression, and its association with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 subtype of breast carcinoma. ER, HER2, IHC, PR
14  2019 Promoter Methylation Status of the Retinoic Acid Receptor-Beta 2 Gene in Breast Cancer Patients: A Case Control Study and Systematic Review. RARbeta2
15  2019 Up-regulated lncRNA GAS5 promotes chemosensitivity and apoptosis of triple-negative breast cancer cells. lncRNAs, RT-qPCR, TNBC
16  2018 Aberrant methylation of mutL homolog 1 is associated with increased risk of non-small cell lung cancer. GEO, MLH1, NSCLC
17  2018 Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways. PCa, TGF-beta
18  2018 Correlation between HDAC4 enhancer DNA methylation and mRNA expression during palatal fusion induced by all-trans retinoic acid. ATRA, CP, HDAC4
19  2018 Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells. ChIP, MGMT, NC, OSCC, TET1
20  2018 Epigenetic regulation of HOTAIR in advanced chronic myeloid leukemia. CML, qPCR, RIP
21  2018 Genome-wide DNA methylome alterations in acute coronary syndrome. ACS, CpG, DM, GO, KEGG, SCAD, SMAD3
22  2018 Hypermethylation of protocadherin gamma subfamily A12 and solute carrier family 19 A 1 promoters contributes to the occurrence and metastasis of colorectal cancer. CRC, CREB, CYLD, PCDH-gamma-A12, PCR, SLC19A1
23  2018 LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer. BCC, LATS2, MI, mRNA
24  2018 Methylation of CDX2 gene promoter in the prediction of treatment efficacy in colorectal cancer. CRC, HPs
25  2018 Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer ---
26  2018 MGMT gene promoter methylation and its correlation with clinicopathological parameters in glioblastomas. ATRX, CI, EGFR, GBM, IDH, OR
27  2018 MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas. MGMT, PSQ
28  2018 MSX1 induces G0/G1 arrest and apoptosis by suppressing Notch signaling and is frequently methylated in cervical cancer. CCK-8, CCND1
29  2018 Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer. CC, CIN, RT-qPCR
30  2018 Promoter Methylation Status of Survival-Related Genes in MOLT- 4 Cells Co-Cultured with Bone Marrow Mesenchymal Stem Cells under Hypoxic Conditions. MSCs, SBS
31  2018 Study on the relationship between the methylation of the MMP-9 gene promoter region and diabetic nephropathy. DN, ELISA, MMP, UACR
32  2018 The Role of Abnormal Methylation of Wnt5a Gene Promoter Regions in Human Epithelial Ovarian Cancer: A Clinical and Experimental Study. qRT-PCR
33  2018 [Relationship between DNMT1 and Methylation of SHP-1 Promoter 2 in K562 Cells]. DNMT1
34  2017 Aberrant gene promoter methylation of E-cadherin, p16 INK4a , p14 ARF , and MGMT in Epstein-Barr virus-associated oral squamous cell carcinomas. EBV, OSCC
35  2017 Aberrant promoter hypermethylation of p16, survivin, and retinoblastoma in gastric cancer. Rb
36  2017 ADAMTSL5 and CDH11: putative epigenetic markers for therapeutic resistance in acute lymphoblastic leukemia. ALL
37  2017 Comparative Assessment of 4 Methods to Analyze MGMT Status in a Series of 121 Glioblastoma Patients. GBM, IHC, MGMT, PSQ, qMSP
38  2017 Detection of OPCML methylation, a possible epigenetic marker, from free serum circulating DNA to improve the diagnosis of early-stage ovarian epithelial cancer. CA125, EOC, fcDNA, OPCML
39  2017 Differential X Chromosome Inactivation Patterns during the Propagation of Human Induced Pluripotent Stem Cells. hiPSCs, HUMARA
40  2017 Effect of ionizing radiation at low dose on transgenerational carcinogenesis by epigenetic regulation. DEN, IR, TSG
41  2017 Evaluation of promoter methylation status of MLH1 gene in Iranian patients with colorectal tumors and adenoma polyps. CRC
42  2017 Gene Expression, DNA Methylation and Prognostic Significance of DNA Repair Genes in Human Bladder Cancer. MSRE-PCR
43  2017 Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B. AFP, CHB, HCC, HCCS1, HCs, TNM
44  2017 HSD11B2, RUNX3, and LINE-1 Methylation in Placental DNA of Hypertensive Disorders of Pregnancy Patients. CH, GH, HDsP, HPLC-FLD, LINE-1, PE, PSQ
45  2017 Hypermethylation of the galectin-3 promoter is associated with poor prognosis of acute-on-chronic hepatitis B liver failure. ACHBLF, CHB, HCs, MELD, PBMCs, RT-PCR
46  2017 Hypomethylated Ubiquitin-Conjugating Enzyme2 Q1 (UBE2Q1) Gene Promoter in the Serum Is a Promising Biomarker for Hepatitis B Virus-Associated Hepatocellular Carcinoma. cfDNA, CHB, HBV, HCC, HCs, LC, UBE2Q1
47  2017 Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma. BORIS, CTCF, ZF
48  2017 Impact of RASSF1A gene methylation on the metastatic axillary nodal status in breast cancer patients. RASSF1A
49  2017 Methylation of SOX1 and VIM promoters in serum as potential biomarkers for hepatocellular carcinoma. CHB, HCC, HCs, LC, PVTT, VIM
50  2017 Promoter methylation and expression of Raf kinase inhibitory protein in esophageal squamous cell carcinoma. ESCC, RKIP
51  2017 Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy. CRC, OR, RASSF1A
52  2017 SHISA3 Promoter Methylation Is a Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Carcinoma. LSCC, qRT-PCR
53  2017 SOCS1 gene promoter methylation status is associated with in-stent restenosis after percutaneous coronary intervention. ISR, SOCS1
54  2017 [DNA methylation modification of BRMS1 in triple-negative breast cancer and its correlation with tumor metastasis]. BRMS1, RT-PCR, TNBC
55  2017 [Effect of AML1-ETO Fusion Protein on Transcriptional Regulation of p14ARF]. ChIP
56  2017 [Effect of interleukin-6 promoter DNA methylation on the pathogenesis of systemic lupus erythematosus]. IL-6, PBMCs, SLE
57  2017 [Interaction between polycyclic aromatic hydrocarbons and p16, FHIT gene CpG island methylation in patients with cervical intraepithelial neoplasias]. GMDR, HPLC, NC, OR, PAHs
58  2016 5-azacytidine inhibits the proliferation of bladder cancer cells via reversal of the aberrant hypermethylation of the hepaCAM gene. AzaC, DNMTs, hepaCAM
59  2016 Aberrant CpG Island Shore Region Methylation of CAV1 Is Associated with Tumor Progression and Poor Prognosis in Gastric Cardia Adenocarcinoma. BGS, Cav-1, GCA, TSS
60  2016 Alcohol and Dietary Folate Intake and Promoter CpG Island Methylation in Clear-Cell Renal Cell Cancer. ccRCC, CI, HR
61  2016 Assessment of Promoter Hypermethylation and Expression Profile of P14ARF and MDM2 Genes in Patients With Pterygium. ---
62  2016 Association of CXCL12 gene promoter methylation with periodontitis in patients with diabetes mellitus type 2. ---
63  2016 Association of TIMP3 expression with vessel density, macrophage infiltration and prognosis in human malignant melanoma. DFS, IHC, OS, TIMP3
64  2016 Changes in expression of WT1 during induced differentiation of the acute myeloid leukemia cell lines by treatment with 5-aza-2'-deoxycytidine and all-trans retinoic acid. AML, ATRA, WT1
65  2016 Detection of OSR2, VAV3, and PPFIA3 Methylation in the Serum of Patients with Gastric Cancer. GC, PCHNTs
66  2016 Epigenetic reactivation of RASSF1A by phenethyl isothiocyanate (PEITC) and promotion of apoptosis in LNCaP cells. BGS, DNMTs, HDACs, PEITC, PI, RASSF1A, TSA
67  2016 High CpG island methylation of p16 gene and loss of p16 protein expression associate with the development and progression of tetralogy of Fallot. EDTA, FQ-PCR, TOF
68  2016 Methylation Analysis of DNA Mismatch Repair Genes Using DNA Derived from the Peripheral Blood of Patients with Endometrial Cancer: Epimutation in Endometrial Carcinogenesis. IHC, MLH1, MMR, MSH2, MSI
69  2016 Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach. MS-MLPA
70  2016 Methylation status and protein expression of RASSF1A in endometriosis. EMS, EMS, RASSF1A
71  2016 Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer. APC, CRC, mCRC, oCRC, RASSF1A
72  2016 Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer. EOC, FANCF, FIGO
73  2016 Promoter hypermethylation of PTPL1, PTPN6, DAPK, p16 and 5-azacitidine inhibits growth in DLBCL. DLBCL, PTPN
74  2016 Promoter methylation profile of GSTP1 and RASSF1A in prostate cancerand benign hyperplasia in Vietnamese men. BPH, PCa
75  2016 PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population. OSCC, PTEN
76  2016 Real-time colorimetric detection of DNA methylation of the PAX1 gene in cervical scrapings for cervical cancer screening with thiol-labeled PCR primers and gold nanoparticles. AUCs, AuNPs, PAX1, qMSP
77  2016 Wnt pathway antagonists, SFRP1, SFRP2, SOX17, and PPP2R2B, are methylated in gliomas and SFRP1 methylation predicts shorter survival. WHO
78  2016 [Methylation status of PCDH10 and RASSF1A gene promoters in colorectal cancer]. CRC, PCDH10, RASSF1A
79  2015 5-Azacitidine induces demethylation of PTPL1 and inhibits growth in non-Hodgkin lymphoma. DLBCL, NHL
80  2015 Aberrant DNA methylation of G-protein-coupled bile acid receptor Gpbar1 predicts prognosis of acute-on-chronic hepatitis B liver failure. ACHBLF, AUC, CHB, HCs, MELD, NPV, PPV
81  2015 Aberrant methylation and expression of DAPk1 in human hypopharyngeal squamous cell carcinoma. DAPK1, HSCC, RT-PCR
82  2015 Assessment of promoter methylation and expression of SIX2 as a diagnostic and prognostic biomarker in Wilms' tumor. AUCs, qRT-PCR, ROC, SIX2, WT
83  2015 Association of HPV with genetic and epigenetic alterations in colorectal adenocarcinoma from Indian population. MSI
84  2015 Berberine exhibits antitumor effects in human ovarian cancer cells. ---
85  2015 Blood-based DNA methylation of DNA repair genes in the non-homologous end-joining (NEHJ) pathway in patient with glioma. NEHJ
86  2015 Comparative detection of aberrantly methylated DNA in preoperative and postoperative stool from patients with colorectal cancers. CRC, post, PRE, sDNA
87  2015 Curcumin inhibits anchorage-independent growth of HT29 human colon cancer cells by targeting epigenetic restoration of the tumor suppressor gene DLEC1. CUR, DLEC1
88  2015 Decitabine treatment could ameliorate primary iron-overload in myelodysplastic syndrome patients. ASF, BSP, HJV, MDS
89  2015 Detecting abnormal methylation of tumor suppressor genes GSTP1, P16, RIZ1, and RASSF1A in hepatocellular carcinoma and its clinical significance. HBsAg, HCC, TSGs
90  2015 Detection of SNCA and FBN1 methylation in the stool as a biomarker for colorectal cancer. CRC
91  2015 Epigenetic changes of the Klotho gene in age-related cataracts. ARCs, IHC, LECs, RT-PCR
92  2015 Fibulin-1 is downregulated through promoter hypermethylation in colorectal cancer: a CONSORT study. BSP, CRC, FBLN1, mRNA, OS, qRT-PCR
93  2015 Hypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma. 5-AzaC, BGS, ccRCC, DFS, RT-PCR, TSGs
94  2015 Increased hypermethylation of glutathione S-transferase P1, DNA-binding protein inhibitor, death associated protein kinase and paired box protein-5 genes in triple-negative breast cancer Saudi females. BC, DAPK, GSTP1, HIN-1, PAX5, ROS, TNBC, TWIST
95  2015 Influence of colorectal cancer tumor suppressor gene CHD5 methylation on its clinical and pathological characteristics. CRC, mRNA, RT-PCR, TSG
96  2015 Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer. HPV
97  2015 Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma. DNMT1
98  2015 Methylation pattern of ALX4 gene promoter as a potential biomarker for blood-based early detection of colorectal cancer. CRC
99  2015 MGMT promoter methylation and glioblastoma: a comparison of analytical methods and of tumor specimens. FFPE, GBM, MGMT, OS, PFS, PSQ
100  2015 MGMT promoter methylation in non-neoplastic brain. IHC, PSQ